Yaz - Side Effects
Yasmin is an oral birth control contraceptive that was introduced to the market by Berlex Laboratories in 2001. Five years later a similar contraceptive, Yaz, became available on the market after Bayer Healthcare purchased Berlex in 2006. A generic form of Yaz/Yasmin, known as Ocella, is also available on the market to those whose prescription medication insurance does not cover the brand name drug. This heavily marketed birth control pill has come under fire for having a misleading and deceptive marketing campaign, according to the Food & Drug Administration (FDA).
In 2003 and 2008, the makers of Yaz were warned by the U.S. Food and Drug Administration (FDA) about problematical statements made in their advertising regarding the oral contraceptive. In October 2008, the FDA sent a letter to Bayer Healthcare citing the various ways in which the manufacturer’s advertisements were misleading, minimized risks associated with the drug, and exaggerated the drugs usefulness. For example, while Yaz is only approved for the treatment of Premenstrual Dysphoric Disorder (PMDD) and moderate acne, the advertisements for the contraceptive led consumers to believe that Yaz could be used to treat all severities of acne as well as Premenstrual Syndrome (PMS). Furthermore, the advertisements seemed to downplay the serious side effects potentially associated with the use of the contraceptive.
After the FDA warning letter, 27 states took legal action against Bayer, for deceptive Yaz advertising. The company was forced to change their misleading ads and committed to a new aggressive ad campaign that corrected previous false and misleading claims about Yaz.
Unfortunately, these precautions came a little too late. Women taking Yaz, have reportedly, experienced serious side effects, such as blood clots, stroke, heart attack, kidney damage, gallbladder problems, and even sudden death. While women with risk factors such as diabetes, high blood pressure, and cardiovascular problems are more prone to experience serious side effects, these symptoms have also occurred in young, healthy women using Yaz. It is believed that the risks posed by this contraceptive are related to a synthetic progestin, drospirenone, used in the manufacture of the contraceptive.
The company's successful advertising campaign helped the manufactured achieve over $600 million in sales by 2007. Unfortunately, many women chose Yaz because the ad campaign hyped the benefits and downplayed the serious risks of the contraceptive.
Due to the serious health related problems experienced from taking Yaz, several lawsuits against the manufacturer are being pursued by women injured as a result of taking the drug. Women involved in the lawsuits, are citing such ailments as, deep vein thrombosis, pulmonary embolism, stroke and heart attacks. Yaz has also been associated with death in many young women.
If you or a loved one took Yaz as a result of Bayer's marketing campaign and suffered from a blood clot, heart attack, stroke, or other serious injuries, contact an experienced pharmaceutical attorney to discuss your legal rights.
Please fill out our online evaluation form or call 1-888-777-3884 as soon as possible to discuss your legal options with one of our experienced civil justice prosecutors.
In 2003 and 2008, the makers of Yaz were warned by the U.S. Food and Drug Administration (FDA) about problematical statements made in their advertising regarding the oral contraceptive. In October 2008, the FDA sent a letter to Bayer Healthcare citing the various ways in which the manufacturer’s advertisements were misleading, minimized risks associated with the drug, and exaggerated the drugs usefulness. For example, while Yaz is only approved for the treatment of Premenstrual Dysphoric Disorder (PMDD) and moderate acne, the advertisements for the contraceptive led consumers to believe that Yaz could be used to treat all severities of acne as well as Premenstrual Syndrome (PMS). Furthermore, the advertisements seemed to downplay the serious side effects potentially associated with the use of the contraceptive.
After the FDA warning letter, 27 states took legal action against Bayer, for deceptive Yaz advertising. The company was forced to change their misleading ads and committed to a new aggressive ad campaign that corrected previous false and misleading claims about Yaz.
Unfortunately, these precautions came a little too late. Women taking Yaz, have reportedly, experienced serious side effects, such as blood clots, stroke, heart attack, kidney damage, gallbladder problems, and even sudden death. While women with risk factors such as diabetes, high blood pressure, and cardiovascular problems are more prone to experience serious side effects, these symptoms have also occurred in young, healthy women using Yaz. It is believed that the risks posed by this contraceptive are related to a synthetic progestin, drospirenone, used in the manufacture of the contraceptive.
The company's successful advertising campaign helped the manufactured achieve over $600 million in sales by 2007. Unfortunately, many women chose Yaz because the ad campaign hyped the benefits and downplayed the serious risks of the contraceptive.
Due to the serious health related problems experienced from taking Yaz, several lawsuits against the manufacturer are being pursued by women injured as a result of taking the drug. Women involved in the lawsuits, are citing such ailments as, deep vein thrombosis, pulmonary embolism, stroke and heart attacks. Yaz has also been associated with death in many young women.
If you or a loved one took Yaz as a result of Bayer's marketing campaign and suffered from a blood clot, heart attack, stroke, or other serious injuries, contact an experienced pharmaceutical attorney to discuss your legal rights.
Please fill out our online evaluation form or call 1-888-777-3884 as soon as possible to discuss your legal options with one of our experienced civil justice prosecutors.
